Malignant Ischemic Stroke and Edema Management
This resource defines large and malignant ischemic strokes, outlines critical intensive care monitoring strategies for cerebral edema, and contrasts clinical efficacy parameters for common osmotherapy protocols.
Duration
00:02:23
File size
1.42 MB
Practitioner-Guided Note
When managing malignant cerebral edema, monitor neurological status closely in the ICU and maintain normothermia. If opting for osmotherapy, note that hypertonic saline and mannitol lack a proven superiority baseline, but require distinct precautions: monitor for volume depletion and renal dysfunction with mannitol, while watching for fluid overload or heart failure risk with hypertonic saline.
Key Takeaways
Malignant strokes involve multiple vascular territories or significant middle cerebral artery hypodensity.
An NIH Stroke Scale score over fifteen strongly correlates with a large infarct.
Hypertonic saline may offer longer-lasting osmotherapy effects compared to mannitol.
Steroids and pentobarbital are entirely ineffective for managing malignant cerebral edema.
Routine intracranial pressure monitoring does not improve ultimate patient outcomes.